Pulmonary toxicity of antineoplastic therapy
- PMID: 1411649
Pulmonary toxicity of antineoplastic therapy
Abstract
Pulmonary toxicity is often encountered in patients receiving antineoplastic therapy. It may produce a wide variety of clinicopathologic syndromes. As new agents are introduced and their adverse effects recognized, clinicians should be ever vigilant about the possibility of pulmonary toxicity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials